FDA Inspection 1294476 — Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd.
The FDA completed an inspection of Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. on Oct 31, 2025 in Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 31, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)